Lite Strategy, Inc. — Director's Dealing 2016

Aug 1, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2016-07-29

Reporting Person: Clemens Kevan (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-29	Option to purchase shares of common stock	$1.36	A	40000	Acquired	2026-07-29	Common Stock par value $0.00000002 (40000)	Direct

Footnotes

F1: The options will vest in equal monthly installments over twelve months.